These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36228923)

  • 1. A Decade of Progress Accelerating Malaria Control in Mali: Evidence from the West Africa International Center of Excellence for Malaria Research.
    Doumbia S; Sogoba N; Diakite M; Toure M; Keita M; Konaté D; Diawara SI; Diarra A; Sanogo D; Kane F; Diakite SAS; Traore K; Thiam SM; Traoré SF; Cisse I; Mihigo J; Coulibaly MB; Dabitao D; Alifrangis M; Barry AE; Müller GC; Beier JC; Shaffer JG
    Am J Trop Med Hyg; 2022 Oct; 107(4_Suppl):75-83. PubMed ID: 36228923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
    Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
    Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The West Africa ICEMR Partnerships for Guiding Policy to Improve the Malaria Prevention and Control.
    Doumbia S; Toure M; Sogoba N; Alifrangis M; Diakite M; Diarra A; Keita M; Konaté D; Diawara SI; Thiam SM; Keita S; Tounkara M; Cissé I; Sanogo V; Magassa MH; Barry AE; Winch PJ; Marker HC; Shaffer JG; Traoré SF; Müller GC; Cui L; Beier JC; Mihigo J
    Am J Trop Med Hyg; 2022 Oct; 107(4_Suppl):84-89. PubMed ID: 36228908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
    PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
    Cairns M; Ceesay SJ; Sagara I; Zongo I; Kessely H; Gamougam K; Diallo A; Ogboi JS; Moroso D; Van Hulle S; Eloike T; Snell P; Scott S; Merle C; Bojang K; Ouedraogo JB; Dicko A; Ndiaye JL; Milligan P
    PLoS Med; 2021 Sep; 18(9):e1003727. PubMed ID: 34495978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in malaria epidemiological factors following the implementation of current control strategies in Dangassa, Mali.
    Touré M; Keita M; Kané F; Sanogo D; Kanté S; Konaté D; Diarra A; Sogoba N; Coulibaly MB; Traoré SF; Alifrangis M; Diakité M; Shaffer JG; Krogstad DJ; Doumbia S
    Malar J; 2022 Feb; 21(1):65. PubMed ID: 35197053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution.
    Diawara H; Walker P; Cairns M; Steinhardt LC; Diawara F; Kamate B; Duval L; Sicuri E; Sagara I; Sadou A; Mihigo J; Eckert E; Dicko A; Conteh L
    Malar J; 2021 Mar; 20(1):128. PubMed ID: 33663488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
    Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
    Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
    Dorsey G; Njama D; Kamya MR; Cattamanchi A; Kyabayinze D; Staedke SG; Gasasira A; Rosenthal PJ
    Lancet; 2002 Dec 21-28; 360(9350):2031-8. PubMed ID: 12504399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
    Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ
    Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.